Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer.
Loading...
Embargo End Date
ICR Authors
Authors
Moynihan, C
Bancroft, EK
Mitra, A
Ardern-Jones, A
Castro, E
Page, EC
Eeles, RA
Bancroft, EK
Mitra, A
Ardern-Jones, A
Castro, E
Page, EC
Eeles, RA
Document Type
Journal Article
Date
2017-11-01
Date Accepted
2017-08-08
Abstract
OBJECTIVE: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes. METHODS: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data were analysed using a framework approach. "Masculinity theory" was used to report the impact of having both a BRCA1/2 mutation and PCa. RESULTS: Eleven of 15 eligible men were interviewed. The umbrella concept of "Ambiguity in a Masculine World" was evident. Men's responses often matched those of women in a genetic context. Men's BRCA experience was described, as "on the back burner" but "a bonus" enabling familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men revealed stereotypical "ideal" masculine responses such as stoicism and control while creating new "masculinities" when faced with the vicissitudes of having 2 gendered conditions. CONCLUSION: Health workers are urged to take a reflexive approach, void of masculine ideals, a belief in which obfuscates men's experience. Research is required regarding men's support needs in the name of equality of care.
Citation
Psycho-oncology, 2017, 26 (11), pp. 1987 - 1993
DOI
Source Title
Publisher
WILEY
ISSN
1057-9249
eISSN
1099-1611
Research Team
Oncogenetics